CSL Behring's Hemgenix, administered just once, cut the number of bleeding events expected over the course of a year by 54%, a key study of the therapy found
Senators, working over the weekend to pass a bill central to Biden's domestic agenda, labored through the morning in hopes of passing the bill before starting an August recess